Provided by Tiger Trade Technology Pte. Ltd.

Quantum Biopharma Ltd.

3.72
+0.07001.92%
Post-market: 3.720.00000.00%16:10 EDT
Volume:189.68K
Turnover:717.52K
Market Cap:30.09M
PE:-0.69
High:3.88
Open:3.63
Low:3.63
Close:3.65
52wk High:21.00
52wk Low:2.07
Shares:8.09M
Float Shares:7.65M
Volume Ratio:1.03
T/O Rate:2.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3537
EPS(LYR):-7.9660
ROE:-621.46%
ROA:-51.84%
PB:3.78
PE(LYR):-0.47

Loading ...

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

GlobeNewswire
·
Aug 10

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances MS Imaging Study with Encouraging Preliminary Results

TIPRANKS
·
Aug 04

Quantum Biopharma Ltd Expected to Post a Loss of 42 Cents a Share - Earnings Preview

Reuters
·
Aug 01

Quantum BioPharma Announces Closing of Debt Settlement

GlobeNewswire
·
Jul 30

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Executive Outlines Lucid-MS Development Strategy and Commercial Growth Plans

TIPRANKS
·
Jul 29

Press Release: Quantum Biopharma Announces Intention to Settle Debt

Dow Jones
·
Jul 21

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Expands Clinical Development of Neuroprotective Therapy

TIPRANKS
·
Jul 16

Why Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Is ‘One to Watch’

TIPRANKS
·
Jul 11

Quantum BioPharma Provides Corporate Update

GlobeNewswire
·
Jul 08

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast

TIPRANKS
·
Jul 02

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study

TIPRANKS
·
Jun 30

Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy

GlobeNewswire
·
Jun 25

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

TIPRANKS
·
Jun 24

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

GlobeNewswire
·
Jun 23

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Proprietary Therapy for MS Treatment

TIPRANKS
·
Jun 10

Broadcom, Quantinuum, Strategy, Tesla, and More Stocks That Explain Today's Market -- Barrons.com

Dow Jones
·
Jun 06

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Builds Diversified Pipeline Across Neurological and Wellness Markets

TIPRANKS
·
Jun 05

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Highlights Lucid-MS and unbuzzd(TM) Growth Opportunities on BioMedWire Podcast

TIPRANKS
·
Jun 03

Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns

GlobeNewswire
·
Jun 02

Quantum BioPharma Provides Corporate Update

GlobeNewswire
·
Jun 02